Exclusion Criteria for EVAR
EVAR is contraindicated when patients have unsuitable anatomy that prevents adequate device fixation and seal, with the most critical exclusions being inadequate proximal neck length (<10-15mm), excessive neck diameter (>32mm) or angulation (>60°), and insufficient iliac access vessels (<5-6mm diameter).
Anatomic Exclusion Criteria
Proximal Neck Characteristics (Most Common Exclusion)
The proximal aortic neck represents the primary anatomic barrier to EVAR 1, 2:
- Neck length: <10-15mm of infrarenal aorta (short neck) - accounts for 54% of anatomic exclusions 1
- Neck diameter: >32mm (wide neck) - represents 40% of exclusions 1
- Neck angulation: >60° relative to aneurysm sac - accounts for 14% of exclusions 1
- Mural thrombus: Extensive thrombus in the proximal neck preventing adequate seal - 10% of exclusions 1
Iliac and Access Vessel Issues
Vascular access problems are the second most common exclusion category 1, 2:
- Small iliac arteries: <5-6mm diameter preventing device delivery - accounts for 47% of exclusions 1
- Severe iliac tortuosity: Preventing safe device navigation - 10% of exclusions 1
- Iliac aneurysms: Bilateral common iliac aneurysms extending to hypogastric arteries without adequate distal seal zone - 21% of exclusions 1
Note: Low-profile delivery systems (accommodating vessels ≥4-5mm) can increase EVAR suitability from 49% to approximately 60% 3, though combinations of other anatomic factors still limit applicability.
Distal Seal Zone
- Inadequate distal landing zone: <10mm of healthy common iliac artery
- Distal neck diameter: Outside device specifications (typically >25mm or <8mm)
Branch Vessel Considerations
- Accessory renal arteries: Originating from the aneurysm sac that would be covered by the graft - 6% of exclusions 1
- Low-lying renal arteries: Limiting proximal seal zone
Clinical Exclusion Criteria
Adherence to Instructions for Use (IFU)
Following manufacturer IFU is a Class I, Level B-NR recommendation 4. Deviation from IFU specifications increases risk of:
- Type I endoleaks
- Device migration
- Late rupture
- Aneurysm-related death
High-Risk Patients Paradox
Critically, patients at highest surgical risk who might benefit most from EVAR are less likely to meet anatomic criteria - only 49% of high-risk patients qualify versus 80% of low-risk patients 1. This creates a clinical dilemma where those who need minimally invasive repair most often cannot receive it.
Gender Disparities
Women are disproportionately excluded from EVAR:
- 60% of women excluded versus 30% of men 1, 2
- Primary reason: smaller iliac artery diameters preventing device delivery
- This represents a significant health equity issue in aneurysm management
Relative Contraindications
Rapid Aneurysm Growth
While not absolute exclusions, these warrant expedited intervention consideration 4:
- Growth ≥5mm in 6 months
- Growth ≥10mm in 12 months
Connective Tissue Disorders
Patients with Marfan syndrome, Ehlers-Danlos, or other heritable aortic diseases should preferentially undergo open repair when feasible due to concerns about progressive aortic degeneration and long-term durability 5.
Common Pitfalls
- Underestimating neck angulation: Standard axial CT can underestimate true angulation; use centerline reconstructions
- Ignoring iliac tortuosity: Even adequate diameter vessels may be unsuitable if severely tortuous
- Overlooking thrombus burden: Heavy thrombus in the neck increases risk of Type I endoleak even with adequate dimensions
- Inadequate assessment of access: Always evaluate femoral arteries, not just iliacs, for cutdown or conduit needs
Long-Term Surveillance Requirements
Patients must be able to comply with lifelong imaging surveillance, as EVAR carries higher rates of:
Poor surveillance compliance is an important relative contraindication, particularly in patients with limited life expectancy or inability to follow up.
Current Applicability
With modern devices and techniques, approximately 49-66% of infrarenal AAAs are anatomically suitable for EVAR 1, 3. The remaining third require open repair or are unsuitable for any intervention. Future device development focusing on smaller delivery profiles and improved proximal fixation in hostile necks could expand applicability to approximately 60% of patients 3.